Semler Scientific, Inc. Q3 FY2022 Earnings Call
· Earnings call transcript and AI-powered summary
- Revenue: $14 million in Q3 2022, flat compared to Q3 2021 ($14 million).
- Revenue Composition:
- Fixed Fee Revenue: $8.6 million (+10% YoY)
- Variable Fee Revenue: $4.9 million (-16% YoY)
- Equipment/Other Revenue: $500,000 (+79% YoY)
- Operating Expenses: $9.6 million, up 10% YoY (from $8.7 million), driven by increased headcount, wage inflation, insurance, and professional fees.
- Net Income: $3.7 million (-11% YoY), EPS of $0.46 diluted (vs. $0.51 diluted in Q3 2021)
- Share Repurchase: 47,500 shares bought for $2 million at an average price of $43.08/share. $15 million remains authorized for repurchase.
- Cash Position: $45.5 million in cash and cash equivalents.
- Headcount: 124 employees as of September 30, 2022 (up from 121 in Q2 2022)
Updated FY 2022 Guidance
- Revenue: $55.5M - $58M (previously $58M - $60M)
- Operating Expenses: $38.8M - $40.3M (previously $42.5M - $44M)
- Income from Operations: $16.7M - $17.7M (increased from prior guidance)
- Key Drivers:
- Continued fixed fee license growth
Continue Reading
Unlock the full AI-powered summary with key highlights, financial performance, and analyst Q&A.
Upgrade to ProfessionalContinue Reading
Unlock the full earnings call transcript with speaker labels and formatted dialogue.
Upgrade to Professional